Beta-alanine supplementation ( DrugBank: Alanine, beta-Alanine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	2

13. Multiple sclerosis/Neuromyelitis optica

---

Clinical trials : 3,342 /  Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03803800 (ClinicalTrials.gov)	January 9, 2019	9/1/2019	Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis	Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis	Multiple Sclerosis	Other: Classic, progressive endurance training;Other: Periodized exercise training;Dietary Supplement: beta-alanine	Hasselt University	NULL	Completed	18 Years	75 Years	All	31	N/A	Belgium
2	NCT03418376 (ClinicalTrials.gov)	February 1, 2017	9/1/2018	Carnosine Loading and Periodized Training in MS and HC	The Impact of Carnosine Loading and Rehabilitation Therapy on Exercise Capacity in Multiple Sclerosis.	Multiple Sclerosis;Exercise Therapy;Dietary Supplement	Dietary Supplement: Beta-alanine supplementation;Other: Exercise intervention	Hasselt University	NULL	Completed	18 Years	75 Years	All	45	N/A	Belgium